362 related articles for article (PubMed ID: 12021313)
1. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.
Darlington PJ; Baroja ML; Chau TA; Siu E; Ling V; Carreno BM; Madrenas J
J Exp Med; 2002 May; 195(10):1337-47. PubMed ID: 12021313
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.
Chikuma S; Imboden JB; Bluestone JA
J Exp Med; 2003 Jan; 197(1):129-35. PubMed ID: 12515820
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function.
Martin M; Schneider H; Azouz A; Rudd CE
J Exp Med; 2001 Dec; 194(11):1675-81. PubMed ID: 11733581
[TBL] [Abstract][Full Text] [Related]
4. Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.
Darlington PJ; Kirchhof MG; Criado G; Sondhi J; Madrenas J
J Immunol; 2005 Jul; 175(2):996-1004. PubMed ID: 16002699
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.
Egen JG; Allison JP
Immunity; 2002 Jan; 16(1):23-35. PubMed ID: 11825563
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 negative signaling via lipid rafts: A new perspective.
Rudd CE; Martin M; Schneider H
Sci STKE; 2002 Apr; 2002(128):pe18. PubMed ID: 11972356
[TBL] [Abstract][Full Text] [Related]
8. The role of CTLA-4 in the regulation and initiation of T-cell responses.
Chambers CA; Krummel MF; Boitel B; Hurwitz A; Sullivan TJ; Fournier S; Cassell D; Brunner M; Allison JP
Immunol Rev; 1996 Oct; 153():27-46. PubMed ID: 9010718
[No Abstract] [Full Text] [Related]
9. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
10. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
[TBL] [Abstract][Full Text] [Related]
11. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
[TBL] [Abstract][Full Text] [Related]
12. TCR subunit specificity of CTLA-4-mediated signaling.
Siu E; Carreno BM; Madrenas J
J Leukoc Biol; 2003 Dec; 74(6):1102-7. PubMed ID: 12972512
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory function of CTLA-4 does not require its tyrosine phosphorylation.
Baroja ML; Luxenberg D; Chau T; Ling V; Strathdee CA; Carreno BM; Madrenas J
J Immunol; 2000 Jan; 164(1):49-55. PubMed ID: 10604992
[TBL] [Abstract][Full Text] [Related]
14. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression.
Chuang E; Alegre ML; Duckett CS; Noel PJ; Vander Heiden MG; Thompson CB
J Immunol; 1997 Jul; 159(1):144-51. PubMed ID: 9200449
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.
Chambers CA; Allison JP
Cold Spring Harb Symp Quant Biol; 1999; 64():303-12. PubMed ID: 11232300
[No Abstract] [Full Text] [Related]
16. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse.
Pentcheva-Hoang T; Egen JG; Wojnoonski K; Allison JP
Immunity; 2004 Sep; 21(3):401-13. PubMed ID: 15357951
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4, a negative regulator of T-lymphocyte activation.
Waterhouse P; Marengère LE; Mittrücker HW; Mak TW
Immunol Rev; 1996 Oct; 153():183-207. PubMed ID: 9010724
[No Abstract] [Full Text] [Related]
18. CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells.
Huang JH; Tykocinski ML
Int Immunol; 2001 Apr; 13(4):529-39. PubMed ID: 11282992
[TBL] [Abstract][Full Text] [Related]
19. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
[TBL] [Abstract][Full Text] [Related]
20. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells.
Wang XB; Zheng CY; Giscombe R; Lefvert AK
Scand J Immunol; 2001 Nov; 54(5):453-8. PubMed ID: 11696196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
